W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > August 2012

FDA: seeks input on Study Data Exchange Standards

From: Kerstin Forsberg <kerstin.l.forsberg@gmail.com>
Date: Wed, 15 Aug 2012 07:57:49 +0200
Message-Id: <BC9FE00B-54D9-4EB1-89F4-D306549C53C6@gmail.com>
To: HCLS hcls <public-semweb-lifesci@w3.org>
FDA seeks "input from industry, technology vendors, and other members of the public regarding the advantages and disadvantages of current and emerging open, consensus-based standards for the exchange of regulated study data. " 

In the annoncement for a meeting 5 November FDA ask for responses, before 5 October, on questions such as "- What are the advantages and disadvantages of HL7 v3 and CDISC ODM?"

And, interestingly, they also ask: "- Are there other open data exchange standards that should be evaluated?"

Is this an opportunity for a semantic web based proposal? 

Kind Regards

Kerstin Forsberg

AstraZeneca






https://www.federalregister.gov/articles/2012/08/14/2012-19748/regulatory-new-drug-review-solutions-for-study-data-exchange-standards-notice-of-meeting-request-for
Received on Wednesday, 15 August 2012 05:58:22 GMT

This archive was generated by hypermail 2.3.1 : Tuesday, 26 March 2013 18:01:12 GMT